DalsnaFinance › IPOs › Crispr Therapeutics AG › IPO

CRISPR Therapeutics AG IPO

Completed

CRISPR Therapeutics AG completed its initial public offering on NASDAQ on October 19, 2016, pricing at $14.00 a share.

Ticker	CRSP
Exchange	NASDAQ
Status	Completed
Listing date	October 19, 2016
Offering price	$14.00
Shares offered	4,000,000
Total raised	$56M

The offering

CRISPR Therapeutics AG sold 4,000,000 shares at $14.00 each on NASDAQ. Multiplied out, that is $56 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $56 million total recorded for the deal.

Company coverage

CRISPR Therapeutics AG — quote, profile and latest news →

Other recent IPOs

Iambic Therapeutics, Inc. · October 13, 2026
Retension Pharmaceuticals, Inc. · October 8, 2026
Frazier Life Sciences Acquisition Corp. II · October 8, 2026
TRex Bio, Inc. · October 6, 2026
Pine Tree Acquisition Corp. · October 5, 2026
Accelevation Holdings Corp. · September 30, 2026
Southport Acquisition Corp. II · September 30, 2026
ROZE AI INC. · September 28, 2026

Source: SEC EDGAR filings for CRISPR Therapeutics AG. This page is general information, not investment advice.